Company profile
NeuroNOS company profile
NeuroNOS is a biopharmaceutical company dedicated to developing innovative treatments for Autism Spectrum Disorder (ASD) and other neurological conditions. The company focuses on regulating nitric oxide (NO) levels in the brain, aiming to address the biological mechanisms underlying ASD and improve cognitive and behavioral functions.
Business identity
- Website
- https://www.neuro-nos.com
- Contact email
- [email protected].
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2023-01-01, Year
Headquarters
- Headquarters
- Panora, Iowa, United States
- Country code
- US
- Continent
- North America